Moreover, the effects of weight loss, metformin, and thiazolidinediones, which are treatments aimed at improving insulin sensitivity, have been evaluated in patients with NAFLD, and these medications have shown some benefit [20]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.